Such effects include a skewing of the Th1:Th2 ratio towards a Th2 response (Ramirez 1996; Franchimont 2000) and the downregulation of FasL (Yang 1995), which should lead to impaired anti-tumour immunity. Here, FASLG is linked to neoplasm.